Showing results (1871-1880 of 1,910) with videos related to
Sort By:
Pageof 191
Elife|April 29, 2017
The MBD7 complex promotes expression of methylated transgenes without significantly altering their methylation statusDongming Li, Ana Marie S Palanca, So Youn Won, et al.Nature|October 5, 2012
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growthSergei I Grivennikov, Kepeng Wang, Daniel Mucida, et al.International Journal of Medical Sciences|April 14, 2025
Integrated Phenotypic and Transcriptomic Analyses of Osteoporosis in Type 2 Diabetic MiceShu-Juan Xing, Ying-Feng Gao, Lu Liu, et al.Pharmacology|January 8, 2008
Pharmacological properties of SD-282 - an alpha-isoform selective inhibitor for p38 MAP kinaseBruce Koppelman, Heather K Webb, Satyanarayana Medicherla, et al.Journal of Zhejiang University. Science. B|August 5, 2020
Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control studyShao-Rui Hao, Ren Yan, Shan-Yan Zhang, et al.JCI Insight|December 23, 2025
Intranasal booster drives class switching and homing of memory B cells for mucosal IgA responseSi Chen, Zhengyuan Zhang, Zihan Lin, et al.Proceedings of the National Academy of Sciences of the United States of America|January 29, 2017
YAP-IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesisKoji Taniguchi, Toshiro Moroishi, Petrus R de Jong, et al.Veterinary Microbiology|January 22, 2016
Novel triple-reassortant H1N1 swine influenza viruses in pigs in Tianjin, Northern ChinaYing-Feng Sun, Xiu-Hui Wang, Xiu-Li Li, et al.Human Reproduction (Oxford, England)|February 18, 2026
Free apical surface hetero-cellular CDH1 homophilic binding is a major mediator of blastocyst-endometrium interaction in humansHanzhang Ruan, Andy Chun Hang Chen, Yuxuan Xue, et al.Annals of Hematology|June 6, 2024
Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trialHeng Mei, Xiaofan Liu, Yan Li, et al.Pageof 191